Schantz A - Search Results

1

First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics/safety in healthy subjects and patients with moderate-to-severe psoriasis.

Zhuang Y, Calderon C, Marciniak SJ Jr, Bouman-Thio E, Szapary P, Yang TY, Schantz A, Davis HM, Zhou H, Xu Z. Zhuang Y, et al. Among authors: schantz a. Eur J Clin Pharmacol. 2016 Nov;72(11):1303-1310. doi: 10.1007/s00228-016-2110-5. Epub 2016 Aug 11. Eur J Clin Pharmacol. 2016. PMID: 27515978 Clinical Trial.

2

Analysis of regulatory guidance on antidrug antibody testing for therapeutic protein products.

Bano N, McKelvey T, Spear N, Yang TY, Shankar G, Schantz A. Bano N, et al. Among authors: schantz a. Bioanalysis. 2019 Dec;11(24):2283-2296. doi: 10.4155/bio-2019-0241. Bioanalysis. 2019. PMID: 31845602

3

Absence of adverse effects in cynomolgus macaques treated with CNTO 95, a fully human anti-alphav integrin monoclonal antibody, despite widespread tissue binding.

Martin PL, Jiao Q, Cornacoff J, Hall W, Saville B, Nemeth JA, Schantz A, Mata M, Jang H, Fasanmade AA, Anderson L, Graham MA, Davis HM, Treacy G. Martin PL, et al. Among authors: schantz a. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6959-65. doi: 10.1158/1078-0432.CCR-04-2623. Clin Cancer Res. 2005. PMID: 16203788

4

Implementing a tiered approach to bioanalytical method validation for large-molecule ligand-binding assay methods in pharmacokinetic assessments.

Watson RG, Clements-Egan A, Schantz A, Ware M, Wu B, Yang TY, Shankar G, Marini JC. Watson RG, et al. Among authors: schantz a. Bioanalysis. 2017 Sep;9(18):1407-1422. doi: 10.4155/bio-2017-0044. Epub 2017 Sep 18. Bioanalysis. 2017. PMID: 28920457

5

Validation of immunoassays used to assess immunogenicity to therapeutic monoclonal antibodies.

Geng D, Shankar G, Schantz A, Rajadhyaksha M, Davis H, Wagner C. Geng D, et al. Among authors: schantz a. J Pharm Biomed Anal. 2005 Sep 15;39(3-4):364-75. doi: 10.1016/j.jpba.2005.04.045. J Pharm Biomed Anal. 2005. PMID: 15963677 Review.

6

Development of a method that eliminates false-positive results due to nerve growth factor interference in the assessment of fulranumab immunogenicity.

Dai S, Schantz A, Clements-Egan A, Cannon M, Shankar G. Dai S, et al. Among authors: schantz a. AAPS J. 2014 May;16(3):464-77. doi: 10.1208/s12248-014-9581-z. Epub 2014 Mar 5. AAPS J. 2014. PMID: 24590506 Free PMC article. Clinical Trial.

7

Detection of low-affinity anti-drug antibodies and improved drug tolerance in immunogenicity testing by Octet(®) biolayer interferometry.

Li J, Schantz A, Schwegler M, Shankar G. Li J, et al. Among authors: schantz a. J Pharm Biomed Anal. 2011 Jan 25;54(2):286-94. doi: 10.1016/j.jpba.2010.08.022. Epub 2010 Sep 24. J Pharm Biomed Anal. 2011. PMID: 20869832

8

Pharmacology and placental transfer of a human alphav integrin monoclonal antibody in rabbits.

Martin PL, Zhou Z, Van den Bulck K, Kwok D, Powers G, Jiao Q, Schantz A, Treacy G. Martin PL, et al. Among authors: schantz a. Birth Defects Res B Dev Reprod Toxicol. 2010 Apr;89(2):116-23. doi: 10.1002/bdrb.20232. Birth Defects Res B Dev Reprod Toxicol. 2010. PMID: 20151458

9

A generic method for the detection of polyethylene glycol specific IgG and IgM antibodies in human serum.

Ehlinger C, Spear N, Doddareddy R, Shankar G, Schantz A. Ehlinger C, et al. Among authors: schantz a. J Immunol Methods. 2019 Nov;474:112669. doi: 10.1016/j.jim.2019.112669. Epub 2019 Oct 12. J Immunol Methods. 2019. PMID: 31614128

10

Immunogenicity of therapeutic monoclonal antibodies.

Pendley C, Schantz A, Wagner C. Pendley C, et al. Among authors: schantz a. Curr Opin Mol Ther. 2003 Apr;5(2):172-9. Curr Opin Mol Ther. 2003. PMID: 12772508 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters